A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. (Q37254077)
Jump to navigation
Jump to search
scientific article published on January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. |
scientific article published on January 2010 |
Statements
A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach (English)
Kelan L H Thomas
Vicki L Ellingrod
Jeffrey R Bishop
1 January 2010
1 reference